C-Peptide guide: types, parameters, brands, and selection tips for accurate diabetes monitoring and clinical use.
Target Keyword: what is c peptide
C-Peptide, or connecting peptide, is a short polypeptide chain produced during the biosynthesis of insulin in the pancreas. It is released into the bloodstream in equimolar amounts with insulin, making it a critical biomarker for evaluating endogenous insulin secretion. This guide is designed for diabetes researchers, clinical diagnosticians, pharmaceutical buyers, and peptide sourcing professionals who require accurate, high-purity C-Peptide for monitoring and clinical use. The core value of C-Peptide lies in its ability to differentiate between type 1 and type 2 diabetes, assess beta-cell function, and guide therapeutic decisions without interference from exogenous insulin.
Understanding the molecular specifications of C-Peptide is essential for reliable assay performance and clinical accuracy. The following technical parameters define high-quality C-Peptide products:
Industry data from the American Diabetes Association (ADA) indicates that C-Peptide levels below 0.2 nmol/L in fasting state confirm type 1 diabetes, while levels above 0.6 nmol/L suggest type 2 diabetes or insulin resistance. Accurate measurement requires peptide purity above 98% to avoid cross-reactivity.
The production of high-grade C-Peptide involves solid-phase peptide synthesis (SPPS) followed by rigorous purification and validation. Key steps include:
C-Peptide is utilized across diverse commercial and research settings:
| Item | Our C-Peptide Product | Ordinary Low-Grade Peptides | Advantages |
|---|---|---|---|
| Purity | ≥99% by HPLC | 85-95% by HPLC | Higher accuracy in assays |
| Endotoxin | <0.5 EU/mg | >5 EU/mg | Safe for clinical use |
| Stability | 24 months at -20°C | 6-12 months at -20°C | Longer shelf life |
| Batch Consistency | CV <3% across batches | CV >10% across batches | Reliable results |
When sourcing C-Peptide in bulk, avoid these common pitfalls:
Our C-Peptide offers distinct benefits for professional users:
Q1: What is the difference between C-Peptide and insulin in diabetes monitoring?
C-Peptide has a longer half-life (30-40 minutes) compared to insulin (5-10 minutes), making it a more stable marker for endogenous insulin secretion. It is not affected by exogenous insulin injections, allowing accurate assessment of beta-cell function.
Q2: How should I reconstitute C-Peptide for ELISA assays?
Reconstitute lyophilized C-Peptide in sterile PBS (pH 7.4) at 1 mg/mL, then dilute to working concentrations. Avoid repeated freeze-thaw cycles; aliquot and store at -20°C for up to 6 months.
Q3: Can C-Peptide be used in cosmetic formulations?
Yes, C-Peptide is incorporated into anti-aging products at low concentrations (0.1-0.5%) to support collagen production and skin hydration. Ensure the peptide is endotoxin-free and formulated with stabilizers to maintain efficacy.